BB50252: Infectious diseases
[Page last updated: 04 August 2021]
| Academic Year: | 2021/2 |
| Owning Department/School: | Department of Biology & Biochemistry |
| Credits: | 15 [equivalent to 30 CATS credits] |
| Notional Study Hours: | 300 |
| Level: | Masters UG & PG (FHEQ level 7) |
| Period: |
|
| Assessment Summary: | CW 50%, EX 50% |
| Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Aims: | The unit aims to provide a critical review of the molecular and clinical aspects of microbial pathogenicity (in humans), infectious disease transmission and development of interventions (such as vaccines) that can be utilised to reduce disease. |
| Learning Outcomes: | By the end of this unit you will be able to:
* Apply understanding to develop a critical awareness of the pathogenesis of disease caused by a number of key pathogens, the mechanisms of infection and host-defense and the emergence of virulence; * Apply conceptual understanding to analyse how and why vaccines are useful for the prevention of disease, how they are developed and the limitations in their development; * Critique a range of interventions for reduction of infectious disease, drawing on the current literature in the field; * Communicate your critical evaluation and analyses through a formal presentation. |
| Content: | Content particularly focuses on pathogenesis of bacterial infections; transmission of infection and strategies to reduce transmission; vaccine immunology; uses and limitations of vaccines to prevent communicable diseases. Specific case studies will highlight where the interactions that occur between a named pathogen and its host. Using examples such as Staphylococcus aureus (the MRSA superbug), it outlines disease management and how this is likely to influence the future evolution of the pathogen. |
| Programme availability: |
BB50252 is Optional (DEU) on the following programmes:Department of Biology & Biochemistry
|
Notes:
|